Jane Street
NAVB

Jane Street’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Jane Street’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,474
Closed -$12K – 6184
2019
Q2 		$12K Buy
+19,474
New +$37.8K ﹤0.01% 5035
2019
Q1 		– Sell
-2,385
Closed -$5K – 6017
2018
Q4 		$5K Buy
2,385
+50
+2% +$206 ﹤0.01% 4839
2018
Q3 		$11K Buy
+2,335
New +$8.85K ﹤0.01% 4996
2018
Q2 		– Sell
-1,508
Closed -$11K – 5965
2018
Q1 		$11K Sell
1,508
-3,291
-69% -$24.6K ﹤0.01% 4723
2017
Q4 		$34K Sell
4,799
-4,983
-51% -$42.2K ﹤0.01% 4457
2017
Q3 		$81K Buy
9,782
+2,344
+32% +$19.9K ﹤0.01% 4295
2017
Q2 		$76K Buy
7,438
+4,807
+183% +$47.5K ﹤0.01% 4195
2017
Q1 		$30K Buy
2,631
+1,710
+186% +$19.4K ﹤0.01% 4030
2016
Q4 		$12K Sell
921
-2,188
-70% -$34.7K ﹤0.01% 3962
2016
Q3 		$57K Sell
3,109
-8,035
-72% -$102K ﹤0.01% 3890
2016
Q2 		$118K Buy
11,144
+3,757
+51% +$73.8K ﹤0.01% 3873
2016
Q1 		$140K Sell
7,387
-2,761
-27% -$53.1K ﹤0.01% 3810
2015
Q4 		$270K Sell
10,148
-20,522
-67% -$713K ﹤0.01% 3229
2015
Q3 		$1.4M Buy
+30,670
New +$1.16M 0.01% 1307
2015
Q1 		– Sell
-1,195
Closed -$45K – 3639
2014
Q4 		$45K Buy
+1,195
New +$32.9K ﹤0.01% 2388
2014
Q3 		– Sell
-1,406
Closed -$42K – 3305
2014
Q2 		$42K Buy
+1,406
New +$45.5K ﹤0.01% 2442
2014
Q1 		– Sell
-1,101
Closed -$46K – 3241
2013
Q4 		$46K Sell
1,101
-7
-0.6% -$274 ﹤0.01% 2240
2013
Q3 		$59K Sell
1,108
-1,794
-62% -$105K ﹤0.01% 2592
2013
Q2 		$155K Buy
+2,902
New +$145K ﹤0.01% 2340

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's NAVB Position: Q3 2019 in Review

Jane Street sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q3 2019, closing a stake of 19,474 shares — an estimated $12K sold.

Jane Street first reported a position in NAVB in Q2 2013 and held it in 19 quarters. The position peaked at $1.4M in Q3 2015. 29 funds tracked by Wall St. Rank hold NAVB as of Q3 2019.

  • Jane Street reported no remaining Navidea Biopharmaceuticals Inc. position as of Q3 2019 after selling out during the quarter.
  • Jane Street sold 19,474 Navidea Biopharmaceuticals Inc. shares in Q3 2019, an estimated $12K.
  • Jane Street first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 19 quarters.
  • Jane Street's Navidea Biopharmaceuticals Inc. position peaked at $1.4M in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.